Separate the diseases
Asthma = variable/reversible narrowing. COPD = persistent obstruction. Pneumonia = inflammatory alveolar fluid/exudate causing gas-exchange failure.
COPD, asthma, pneumonia, respiratory assessment, oxygen devices, ABGs, acid-base balance, priorities, delegation, PERSON care planning, and medications - organized for fast clinical reasoning.
Asthma = variable/reversible narrowing. COPD = persistent obstruction. Pneumonia = inflammatory alveolar fluid/exudate causing gas-exchange failure.
Less wheezing is not improvement when airflow is critically low. Silent chest, exhaustion, falling LOC, or inability to speak are red flags.
Always use the same order: pH → PaCO2 → HCO3 → compensation → PaO2.
SABA = rapid rescue. ICS/LABA/LAMA/leukotriene/biologic therapies are maintenance unless the prescribed asthma plan specifically says otherwise.
This page is built from the supplied Completed Oxygenation Study Guide. The professor's Oxygenation Lectures Parts 1 and 2 remain the primary course source, with only the study guide's labeled supplements used to fill objective gaps.
The fastest way to separate the disorders is to ask what is physically blocking airflow or gas exchange: narrowed inflamed airways in asthma, persistent airflow obstruction from mucus/alveolar destruction in COPD, or inflammatory fluid/exudate in pneumonia.
| Condition | Etiology / trigger | Core pathophysiology | NCLEX recognition cue |
|---|---|---|---|
| Chronic bronchitis (COPD) | Smoking is the major lecture risk; also occupational fumes/dust, air pollution, infection/aging, genetics. | Chronic bronchial inflammation + excess thick mucus narrow airways and impair clearance. Uneven ventilation causes V/Q mismatch; hypoxemia and CO2 retention can develop. | Chronic cough + sputum + dyspnea; coarse crackles/mucus; persistent obstruction. |
| Emphysema (COPD) | Usually smoking/exposure; alpha-1 antitrypsin deficiency is an inherited cause. | Alveolar walls are destroyed and elastic recoil is lost. Small airways collapse on exhalation → air trapping/hyperinflation and reduced gas-exchange surface area. | Hyperinflation/barrel chest + diminished breath sounds + prolonged exhalation/air trapping. |
| Asthma | Atopy/allergens; exercise, stress, heat/cold, infections; late-onset and obesity phenotypes can occur. | Chronic airway inflammation with episodic bronchoconstriction, mucosal edema, and mucus. Airflow limitation is characteristically variable and usually reversible. | Episodic wheeze/cough/chest tightness, prolonged expiration, trigger pattern, variable/reversible airflow. |
| Pneumonia | Acute lung infection, usually microorganisms; lecture categories include CAP, HAP/VAP, HCAP, opportunistic; aspiration can also cause pneumonia. | Inflammatory edema/exudate fills alveoli/interstitium. Poorly ventilated alveoli remain perfused → low V/Q or shunt-like physiology → hypoxemia. | Fever/chills + cough/sputum + crackles/pleuritic pain + new infiltrate/oxygenation decline. |
| Condition | Lecture risks | Web completion / at-risk groups |
|---|---|---|
| COPD | Smoking; occupational chemicals/fumes/dust; air pollution; infection; aging; genetics; AAT deficiency. | Long cumulative inhalational exposure; secondhand smoke/combustion exposure. Consider AAT deficiency when COPD is unusually early/severe or occurs with limited smoking exposure. |
| Asthma | Atopy; allergens; exercise; stress; heat/cold; respiratory infections; adult onset; obesity phenotype. | Family/personal allergic disease, occupational sensitizers/irritants, and tobacco/vape exposure may increase risk or worsen control. Normal IgE/eosinophils do not exclude asthma. |
| Pneumonia | Opportunistic pneumonia in immunocompromised patients; aspiration precautions emphasized. | Older adults; chronic lung/heart/liver disease or diabetes; smoking; excessive alcohol; immunocompromise; dysphagia/decreased LOC; recent hospitalization/ventilation for HAP/VAP risk. |
| What to assess | Lecture anchor | Why it matters |
|---|---|---|
| Respiratory rate / pattern | Normal adult RR 12-20; bradypnea <12; tachypnea >20; assess depth and effort. | Trend is often more useful than one value; increasing work of breathing can precede a major SpO2 drop. |
| Breath sounds | Crackles/rales, rhonchi, wheezing, stridor; note diminished/absent areas. | Wheeze = narrowed airway; rhonchi/coarse sounds = secretions; crackles = fluid/opening small airways; stridor = upper-airway emergency. |
| Oxygenation | Pulse oximetry, ABG/VBG; assess dyspnea, accessory muscles, cyanosis. | SpO2 is a screening measure; ABG directly evaluates PaO2/PaCO2 and acid-base status. |
| Cough / sputum / pain | Character, amount/color of sputum; pleuritic pain; hemoptysis. | Change from baseline may signal infection or exacerbation. |
| Condition | Chronic / common findings | Acute deterioration cues |
|---|---|---|
| COPD | Dyspnea, chronic cough/sputum; diminished sounds or coarse crackles; hyperinflation, barrel chest, hyperresonance, retractions; hypoxemia/cyanosis; polycythemia can occur. | More dyspnea/sputum, new mental-status change, worsening ABG, respiratory failure; infection/environmental irritants are common triggers. |
| Asthma | Variable cough/wheeze/chest tightness; prolonged expiration, air trapping/hyperinflation; night symptoms may occur. | Tachypnea/tachycardia, orthopnea, accessory muscles, diaphoresis, inability to speak full sentences, worsening hypoxemia. Silent chest is an ominous sign of minimal airflow. |
| Pneumonia | Cough with sputum, dyspnea, pleuritic chest pain, fever/chills, fatigue; crackles and hypoxemia are common. | Hypotension, tachycardia, severe hypoxemia, new confusion, increasing work of breathing, sepsis or respiratory failure. |
| Test | COPD | Asthma | Pneumonia / nursing note |
|---|---|---|---|
| Spirometry / PFT | Lecture: FVC, FEV1, FEV1/FVC. Current GOLD confirms COPD with post-bronchodilator FEV1/FVC <0.70. Lecture airflow grades: FEV1 ≥80%, 50-79%, 30-49%, <30%. | Looks for variable expiratory airflow and bronchodilator response. PEF can be used when spirometry is unavailable or for monitoring. | Not the primary diagnostic test for acute pneumonia; may be deferred during acute illness. |
| Chest x-ray | May show hyperinflation; also helps evaluate other causes/complications. | Often normal between attacks; useful when another diagnosis/complication is suspected. | Commonly shows a new infiltrate/consolidation when clinical pneumonia is present. |
| CT chest | Can define emphysema, bullae, alternative diagnoses/complications when ordered. | Selected cases, not routine uncomplicated asthma. | Selected severe/complicated or unclear cases; can define abscess/effusion. |
| ABG | May show hypoxemia/hypercapnia. Lecture COPD example: low pH, high PaCO2, high HCO3, low PaO2 = partially compensated respiratory acidosis. | Used in severe exacerbation/respiratory failure, not routine stable asthma. | Assesses oxygenation/ventilation in severe illness. |
| AAT level | Detects alpha-1 antitrypsin deficiency. | Not diagnostic for asthma. | Not a routine pneumonia test. |
| IgE / eosinophils / skin testing | Not diagnostic for COPD. | Supports allergic/Type 2 phenotype; normal values do not rule asthma out. | Not routine pneumonia testing. |
| Sputum / blood cultures | Obtained when infection is suspected and severity/context warrants. | Not routine unless infection is being evaluated. | Lecture includes sputum specimens and blood cultures; obtain before antibiotics when ordered and when it will not delay urgent therapy. |
| Bronchoscopy | Selected diagnostic/therapeutic use. | Selected use. | Lecture lists bronchoscopy; useful for airway sampling/obstruction or complicated cases. |
| V/Q scan | Not a COPD diagnostic test; evaluates ventilation vs perfusion when PE is suspected. | May be used when PE is a competing diagnosis, not routine asthma. | Not routine pneumonia; can help evaluate PE in appropriate patients. |
| Device | Typical web-supplement range | Nursing / exam cue |
|---|---|---|
| Nasal cannula | 1-6 L/min; about 24-44% FiO2 | Comfortable; patient can eat/talk. Humidification may be needed with higher/prolonged flow per policy. |
| Simple mask | 6-10 L/min; about 28-50% FiO2 | Do not run below device minimum because CO2 rebreathing can occur. |
| Venturi mask | Adapter sets a precise FiO2, commonly ~24-60% | Useful when controlled oxygen concentration is important; do not change adapter/flow arbitrarily. |
| Non-rebreather | 10-15 L/min; about 60-80% FiO2 | High concentration for a spontaneously breathing patient. Keep reservoir bag partially inflated. |
| HFNC | Up to ~60 L/min; FiO2 independently adjustable up to high concentrations | Heated/humidified high flow; decreases work of breathing and can improve oxygenation. |
| CPAP | One continuous positive airway pressure | Keeps airways/alveoli open; patient must be breathing spontaneously. |
| BiPAP | Higher inspiratory + lower expiratory pressure | Provides pressure support plus PEEP-like expiratory pressure; useful in selected ventilatory failure. |
| Complication | Cause / recognition | Prevention / management focus |
|---|---|---|
| Status asthmaticus | Severe asthma exacerbation with escalating obstruction; tachypnea, hypoxemia, accessory muscles, inability to speak; silent chest can occur. | Emergency: oxygen, repeated/continuous inhaled SABA, ipratropium, systemic corticosteroid; IV fluids as ordered; prepare for intubation/ventilation if failing. |
| COPD respiratory failure | Exacerbation/infection can worsen V/Q mismatch and CO2 retention; mental-status change and worsening ABG are danger signs. | Titrate oxygen to ordered target, bronchodilators, treat trigger, airway clearance, ABG monitoring; NIV (BiPAP) or invasive ventilation when indicated. |
| Pulmonary hypertension / cor pulmonale | Chronic hypoxemia raises pulmonary vascular resistance → right-heart strain/failure. | Prevent/treat chronic hypoxemia as prescribed; manage COPD; watch edema/JVD/weight; coordinate cardiopulmonary care. |
| Pneumothorax | Bullae may rupture; severe lung disease increases risk. Sudden dyspnea/pleuritic pain with unilateral decreased sounds is concerning. | Urgent assessment, oxygen/support, imaging; chest tube/other intervention as ordered. Escalate immediately if unstable. |
| Pneumonia / recurrent infection | Impaired clearance and COPD increase infection risk. | Vaccination, smoking cessation, hand hygiene, early evaluation/treatment. |
| Pleural effusion / pleurisy / lung abscess | Pneumonia can extend to pleural space or form localized infection. | Antimicrobial therapy and drainage/procedures when ordered; monitor pain, breath sounds, oxygenation and sepsis. |
| ARDS | Severe inflammatory lung injury from pneumonia/sepsis can cause refractory hypoxemia. | Rapid critical-care escalation; lung-protective ventilation/oxygenation strategy per team. |
| Sepsis | Infection with organ dysfunction: hypotension, altered mentation, poor perfusion, rising O2 need. | Recognize early; cultures/lactate per protocol; prompt antimicrobials and fluids/vasopressors as ordered; monitor perfusion/urine output. |
| Component | Lecture normal | What it tells you |
|---|---|---|
| pH | 7.35-7.45 | Overall acidemia (<7.35) or alkalemia (>7.45). |
| PaCO2 | 35-45 mmHg | Respiratory component. CO2 is an acid: high CO2 → acid direction; low CO2 → base direction. |
| HCO3- | 22-26 mEq/L | Metabolic/renal component. High HCO3 → base direction; low HCO3 → acid direction. |
| PaO2 | 80-100 mmHg | Arterial oxygenation. Lecture hypoxemia scale is listed below; laboratory ranges vary. |
| Pattern | pH | PaCO2 / HCO3 | Interpretation |
|---|---|---|---|
| Uncompensated | Abnormal | Primary value abnormal; the other system is still near normal. | No meaningful compensation yet. |
| Partially compensated | Still abnormal | Both PaCO2 and HCO3 are abnormal in opposite physiologic directions. | Compensation has begun but pH is not normal. |
| Fully compensated | 7.35-7.45 | Both PaCO2 and HCO3 are abnormal. | Use which side of 7.40 the pH lies on plus clinical context to identify the original process; mixed disorders are possible. |
| ABG | Interpretation | Why |
|---|---|---|
| 7.30 / 52 / 24 / PaO2 65 | Uncompensated respiratory acidosis + hypoxemia | pH acid, CO2 acid, HCO3 normal. |
| 7.32 / 55 / 29 | Partially compensated respiratory acidosis | pH still acid; high CO2 primary; high HCO3 compensating. |
| 7.37 / 52 / 30 | Fully compensated respiratory acidosis (exam shorthand) | pH normal but on acid side; CO2 high, HCO3 high. |
| 7.48 / 30 / 24 | Uncompensated respiratory alkalosis | pH base, CO2 base, HCO3 normal. |
| 7.28 / 30 / 16 | Partially compensated metabolic acidosis | pH acid; HCO3 low primary; CO2 low compensation. |
| 7.48 / 48 / 32 | Partially compensated metabolic alkalosis | pH base; HCO3 high primary; CO2 high compensation. |
| Disorder | Lecture causes | Common manifestations / compensation |
|---|---|---|
| Respiratory acidosis | “DEPRESS”: Drugs, Edema, Pneumonia, Respiratory-center damage, Emboli, bronchial Spasms/asthma, Sac elasticity damage/COPD-emphysema. Also anesthesia/drug overdose, atelectasis. | Hypoventilation, dyspnea, headache, drowsiness/confusion, weakness, low BP, dysrhythmias; hyperkalemia may occur. Kidneys retain HCO3/excrete acid over time. |
| Respiratory alkalosis | Hyperventilation, increased temperature, salicylate toxicity, extreme anxiety, pulmonary embolus/fear, excessive mechanical ventilation; lecture also lists gram-negative bacteria. | Deep rapid breathing, lightheadedness, tingling/numbness, tachycardia, confusion, nausea, seizures if severe; hypokalemia can occur. Kidneys lower HCO3 over time. |
| Metabolic acidosis | DKA, acute/chronic kidney injury, malnutrition, severe diarrhea; increased acid production or loss of HCO3. | Kussmaul/compensatory hyperventilation, headache, warm/flushed skin, hypotension, N/V, confusion/drowsiness, hyperkalemia. Lungs blow off CO2. |
| Metabolic alkalosis | Excess vomiting/gastric suction, diuretics/volume depletion, excessive antacid/NaHCO3, hyperaldosteronism. | Compensatory hypoventilation, restlessness then lethargy/confusion, dysrhythmias, tremor/cramps/tingling, hypokalemia. Lungs retain CO2. |
| Domain | Respiratory-relevant data |
|---|---|
| P | Age; baseline LOC/orientation/cognition; emotional state/anxiety; coping; support system/living arrangement; teaching needs. New mental-status change can signal worsening oxygenation/ventilation. |
| E | Only when relevant: urine output for hydration/perfusion, vomiting/diarrhea causing fluid/electrolyte loss, constipation from meds/immobility, diaphoresis during significant respiratory distress. |
| R | Pain (especially pleuritic/chest pain); activity/ambulation; ADLs/activity tolerance; sleep/rest. Focus on fatigue, exertional dyspnea, and sleep disruption from cough/breathing difficulty. |
| S | Allergies/reactions; fall risk/new confusion; sedative use; tobacco/drug/alcohol use; temperature; WBC; immunization status; IV-site status when IV therapy is present. |
| O | BP; HR/rhythm; RR/character; SpO2; room air vs oxygen and L/min; pulses/cap refill; edema; skin color; lung sounds; cough/sputum; SOB/DOE; chest pain; relevant labs/x-ray. Core respiratory domain. |
| N | Diet/% eaten; fluid I/O; height/weight/BMI; hydration/IV fluids; glucose/insulin when steroids matter; Na, K, Cl, CO2, BUN, creatinine, glucose when ordered. |
| Care-plan element | Example |
|---|---|
| Nursing problem | Impaired gas exchange related to ventilation-perfusion imbalance/airflow obstruction as evidenced by hypoxemia, dyspnea and abnormal ABG/SpO2. |
| Goal / outcome | Patient maintains prescribed oxygenation target, shows reduced work of breathing, and stable/improving mental status and ABG trend. |
| Interventions | Position upright; assess RR/effort/breath sounds/mental status; titrate oxygen only per order/protocol; administer bronchodilators; coach pursed-lip breathing; promote secretion clearance; obtain ABG/notify provider for worsening status; prepare NIV/escalation if indicated. |
| Rationales | Positioning/bronchodilation improve ventilation; controlled oxygen treats hypoxemia; breathing techniques prolong exhalation; mental-status/ABG changes may reveal CO2 retention or impending failure. |
| Evaluation | Compare with baseline and goal: SpO2/PaO2, PaCO2/pH, RR/effort, speech, dyspnea rating, breath sounds, activity tolerance. |
| Disease | Likely first respiratory problems |
|---|---|
| Asthma | Ineffective breathing pattern / impaired gas exchange from acute bronchoconstriction; ineffective airway clearance when mucus is significant. |
| COPD | Impaired gas exchange, ineffective airway clearance, activity intolerance, imbalanced nutrition and anxiety may coexist. |
| Pneumonia | Impaired gas exchange + ineffective airway clearance related to inflammatory exudate/secretions; hyperthermia, pain and fluid deficits may also need care. |
| Patient | Teach | How to verify learning |
|---|---|---|
| COPD | Smoking cessation; inhaler sequence/technique; pursed-lip and huff cough; oxygen fire safety; pacing/energy conservation; nutrition; vaccination; recognize exacerbation: increased dyspnea/sputum, fever, confusion, falling SpO2. | Teach-back + return demonstration of inhaler/breathing technique; patient states when to call/seek emergency care. |
| Asthma | Controller vs reliever; action-plan zones; personal-best PEF; trigger reduction; spacer/MDI or DPI technique; rinse mouth after ICS; do not rely on SABA alone if current plan uses an ICS-containing reliever/controller. | Patient calculates zones, demonstrates peak flow/inhaler, and explains red-zone response. |
| Pneumonia | Take antibiotics exactly as prescribed if ordered; hydration/rest; cough/deep breathing and mobility; aspiration precautions if relevant; smoking cessation; hand hygiene; influenza/pneumococcal vaccination; warning signs. | Patient states medication schedule, prevention steps, and when worsening dyspnea, confusion, persistent fever or dehydration requires care. |
| Situation / red flag | Why it is dangerous | Immediate nursing priority |
|---|---|---|
| Asthma: silent chest, unable to speak full sentences, exhaustion, falling LOC, quick-relief med not helping | Minimal airflow / impending respiratory arrest. | ABCs, high-Fowler if tolerated, oxygen, rapid response/emergency help, bronchodilator treatment, prepare ventilation. |
| Any patient: severe hypoxemia, cyanosis with distress, RR rapidly worsening, new confusion or somnolence | Brain/heart may be under-oxygenated; hypercapnia may also depress consciousness. | Assess airway/ventilation, verify pulse-ox signal/device, apply/titrate ordered oxygen, call urgent help, ABG/ventilatory support as indicated. |
| COPD: increasing drowsiness + rising PaCO2 / falling pH | Acute-on-chronic ventilatory failure. | Notify/rapid response based on severity; support ventilation, bronchodilators, controlled oxygen, prepare NIV/intubation. |
| Pneumonia: hypotension, tachycardia, altered mentation, low urine output, escalating oxygen need | Sepsis/shock or respiratory failure. | Sepsis/rapid-response pathway: oxygenation, IV access/labs/cultures, antibiotics/fluids as ordered, perfusion reassessment. |
| Sudden unilateral severe dyspnea/pleuritic pain + markedly decreased breath sounds | Possible pneumothorax; tension physiology can obstruct circulation. | Emergency assessment and provider/rapid response; oxygen/support; prepare decompression/chest-tube care if ordered. |
| New stridor | Upper-airway narrowing. | Airway emergency: summon help, support oxygenation, prepare advanced-airway treatment. |
| Non-rebreather reservoir collapses or oxygen supply disconnects | High-concentration device is no longer functioning; suffocation risk with one-way valves. | Restore oxygen flow immediately, assess patient/SpO2, replace equipment as needed. |
Nuclear-medicine comparison of air reaching lung regions (V) with blood reaching them (Q). A mismatch can support pulmonary embolism evaluation.
Forced expiratory volume in the first second of a forced exhalation. Used to quantify airflow obstruction and grade COPD airflow limitation.
Forced vital capacity: total volume forcefully exhaled after a full inspiration. The FEV1/FVC ratio expresses how much exits in the first second.
Noninvasive estimate of SpO2. Does not measure PaCO2 or ventilation. Poor perfusion, motion, cold skin, nail products and device bias can affect accuracy; confirm unexpected values clinically/with ABG when needed.
Genetic tendency to develop IgE-mediated allergic responses; lecture links atopy with allergic asthma.
Biomarkers that may support allergic/Type 2 asthma phenotyping. Elevated values support the pattern; normal values do not exclude asthma.
Protective antiprotease made mainly by the liver. Inherited deficiency can damage lungs/liver and is a COPD risk factor, especially emphysema.
Inhale gently through nose, exhale slowly through partially closed lips. Prolongs exhalation, reduces dynamic airway collapse/air trapping, slows RR, and can reduce dyspnea in COPD.
Airway-clearance technique using a medium/deep breath followed by forceful open-glottis exhalation (“huff”) to move mucus with less airway collapse than repeated hard coughing.
Handheld device measuring peak expiratory flow (PEF). Asthma plans compare today's value with personal best.
Continuous positive airway pressure: one set positive pressure through the respiratory cycle in a spontaneously breathing patient. Helps splint airways/alveoli open and improve oxygenation.
Bilevel positive airway pressure: higher inspiratory pressure and lower expiratory pressure. Provides ventilatory assistance plus airway/alveolar splinting.
Bedside collateral-circulation assessment before radial arterial puncture in settings where facility policy requires it; lecture places it before ABG draw.
Primary CO2 retention/hypoventilation: pH <7.35 with PaCO2 >45 before/without full compensation.
Primary excessive CO2 loss/hyperventilation: pH >7.45 with PaCO2 <35 before/without full compensation.
Primary bicarbonate deficit or acid gain: pH <7.35 with HCO3 <22 before/without full compensation.
Primary bicarbonate excess or hydrogen loss: pH >7.45 with HCO3 >26 before/without full compensation.
The other system is responding, so PaCO2 and HCO3 are both abnormal, but pH is still outside 7.35-7.45.
Nursing-exam shorthand: pH has returned to 7.35-7.45 while PaCO2 and HCO3 remain abnormal. Determine primary disorder from direction/pattern and clinical context.
| Team member | Role in COPD / asthma / pneumonia care |
|---|---|
| Primary provider / hospitalist | Coordinates diagnosis, treatment, escalation and discharge plan. |
| Pulmonologist | Complex COPD/asthma, recurrent exacerbations, advanced testing, bronchoscopy, NIV/ventilation planning, lung-reduction/transplant evaluation. |
| Respiratory therapist | Oxygen devices, nebulizers/inhalers, airway-clearance therapies, NIV/ventilator management, respiratory teaching. |
| Pharmacist | Inhaler selection/technique, interaction review, theophylline safety, steroid/bronchodilator optimization, smoking-cessation pharmacotherapy. |
| Dietitian | COPD weight loss/cachexia or obesity, nutrient-dense small meals, hydration and individualized calorie/protein goals. |
| PT / OT / pulmonary rehab | Conditioning, exercise tolerance, energy conservation, ADLs and functional recovery. |
| Speech-language pathologist | Swallow evaluation and aspiration-prevention plan when dysphagia is suspected. |
| Infectious disease / microbiology | Severe, resistant, opportunistic or complicated pneumonia; antimicrobial stewardship and culture interpretation. |
| Case management / social work | Home oxygen/equipment, insurance/med access, transportation, rehabilitation, smoking-cessation/community resources. |
| Palliative care / hospice | Dyspnea/symptom management, goals-of-care discussion, advance-care planning, caregiver support in advanced disease. |
| Condition | Core pattern | Hallmark clue | Priority / treatment focus |
|---|---|---|---|
| Asthma | Variable/reversible airway obstruction | Wheeze + prolonged expiration; trigger pattern; PEF zones. Silent chest = severe. | SABA/acute bronchodilation + oxygen; anti-inflammatory controller; action plan. |
| Chronic bronchitis | COPD airway inflammation + mucus | Chronic productive cough/sputum, coarse sounds. | Smoking cessation, bronchodilators, airway clearance, rehab, oxygen if prescribed. |
| Emphysema | COPD alveolar destruction + loss of recoil | Air trapping/hyperinflation, barrel chest, diminished sounds. | Prolong exhalation/pursed lips, bronchodilators, rehab; selected surgery. |
| Pneumonia | Infectious alveolar inflammation/exudate | Fever/chills + sputum + crackles/pleuritic pain + infiltrate. | Oxygenation, timely antimicrobials when indicated, hydration/airway clearance, sepsis surveillance. |
| COPD exacerbation | Acute worsening dyspnea/sputum ± infection | Mental-status change, worsening ABG, hypercapnia/respiratory acidosis. | Controlled oxygen + bronchodilators + trigger treatment; NIV/ventilation if failing. |
| Acute bronchitis | Acute bronchial inflammation | Productive cough; low-grade fever/malaise; often self-limited. | Supportive care, fluids/rest, symptom control; lecture: usually no antibiotics. |
| Respiratory acidosis | pH down, PaCO2 up | Hypoventilation / CO2 retention. | Improve ventilation and treat cause; renal HCO3 compensation if chronic. |
| Respiratory alkalosis | pH up, PaCO2 down | Hyperventilation, tingling/lightheadedness. | Treat cause of hyperventilation. |
| Metabolic acidosis | pH down, HCO3 down | DKA/renal failure/diarrhea; Kussmaul. | Treat cause; lungs lower CO2. |
| Metabolic alkalosis | pH up, HCO3 up | Vomiting/NG suction/diuretics; hypokalemia. | Correct cause/volume-electrolytes as ordered; lungs retain CO2. |
| Lecture / course point | Current-practice clarification |
|---|---|
| COPD: FEV1/FVC <70% diagnostic | Use post-bronchodilator FEV1/FVC <0.70 to confirm COPD. FEV1 grade alone does not determine all modern treatment decisions. [W1] |
| COPD: “hypoxic drive” | Do not withhold needed oxygen. In acute COPD with hypercapnia risk, titrate to the ordered controlled target and reassess ventilation/ABG. |
| Asthma: SABA is rescue medication | Correct for rapid bronchodilation, but current GINA recommends an ICS-containing treatment strategy and recommends against SABA-only treatment for adults/adolescents. [W2] |
| Pneumonia types include HCAP | Know for lecture questions, but modern ATS/IDSA guidelines removed HCAP as a separate category. [W4] |
| Pneumonia prevention: Pneumovax 23 | Know the lecture example, but current CDC adult pneumococcal schedules include PCV15/20/21 with PPSV23 used in selected sequences. [W6] |
| Pulse ox as oxygen measure | Useful screening, but confirm unexpected/critical values and assess the patient. ABG provides PaO2/PaCO2; pulse ox does not measure CO2. [W9-W10] |
MDI = slow inhalation.
DPI = quick/deep inhalation.
ICS = rinse and spit after.
Controller ≠ rescue.
| Device | High-yield technique |
|---|---|
| MDI | Shake/prime as product directs; exhale; seal lips; press canister while inhaling slowly and deeply; hold breath about 10 sec if able; wait between puffs as directed. Spacer improves coordination for compatible MDIs. |
| DPI | Load dose; exhale away from device; seal lips; inhale quickly and deeply; hold breath; do not blow moisture into device. No spacer. |
| Nebulizer | Place prescribed solution in cup, connect to flow/compressor, sit upright, breathe slowly/deeply through mouthpiece/mask until mist stops; clean equipment per instructions. |
| ICS aftercare | Rinse mouth and spit after inhaled corticosteroid to reduce thrush/hoarseness risk. |
Primary course source: Kuhn, K., MSN, RN. Interference with the Intake of Oxygen - Part 1. County College of Morris course lecture PDF, provided by the student. (L1)
Primary course source: Kuhn, K., MSN, RN. Interference with the Intake of Oxygen - Part 2. County College of Morris course lecture PDF, provided by the student. (L2)
Primary course source: Unit 7 Oxygenation Study Guide - Health Need: Oxygen; Health Problem: Interference with the Intake of Oxygen. Course objective sheet, provided by the student.
Course source: County College of Morris. NUR 121 - Fundamentals of Nursing PERSON Assessment Guide. Used for Objective 10 only.
W1. GOLD. 2026 GOLD Report and Pocket Guide. https://goldcopd.org/2026-gold-report-and-pocket-guide/
W2. GINA. 2026 GINA Strategy Report. https://ginasthma.org/wp-content/uploads/2026/05/GINA-2026-Strategy-Report-WMS.pdf
W3. ATS/IDSA. Diagnosis and Treatment of Adults with Community-Acquired Pneumonia. https://www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults/
W4. ATS/IDSA. Hospital-Acquired and Ventilator-Associated Pneumonia Guideline. https://www.idsociety.org/practice-guideline/hap_vap/
W5. CDC. Pneumonia Risk Factors. https://www.cdc.gov/pneumonia/risk-factors/index.html
W6. CDC. Pneumococcal Vaccine Recommendations, updated February 2026. https://www.cdc.gov/pneumococcal/hcp/vaccine-recommendations/index.html
W7. CDC. 2026-2027 Flu Season / annual influenza vaccination guidance. https://www.cdc.gov/flu/season/2026-2027.html
W8. Merck Manual Professional. Acid-Base Disorders and compensation tables. https://www.merckmanuals.com/professional/nephrology/acid-base-regulation-and-disorders/acid-base-disorders
W9. MedlinePlus. Arterial Blood Gas (ABG) Test. https://medlineplus.gov/lab-tests/arterial-blood-gas-abg-test/
W10. MedlinePlus. Pulse Oximetry. https://medlineplus.gov/lab-tests/pulse-oximetry/
W11. NCSBN. Delegation / National Guidelines for Nursing Delegation. https://www.ncsbn.org/nursing-regulation/practice/delegation.page
W12. MedlinePlus. Albuterol Oral Inhalation. https://medlineplus.gov/druginfo/meds/a682145.html
W13. MedlinePlus. Levalbuterol Oral Inhalation. https://medlineplus.gov/druginfo/meds/a603025.html
W14. MedlinePlus. Salmeterol Oral Inhalation. https://medlineplus.gov/druginfo/meds/a695001.html
W15. MedlinePlus. Theophylline. https://medlineplus.gov/druginfo/meds/a681006.html
W16. MedlinePlus. Ipratropium Oral Inhalation. https://medlineplus.gov/druginfo/meds/a695021.html
W17. MedlinePlus. Tiotropium Oral Inhalation. https://medlineplus.gov/druginfo/meds/a604018.html
W18. MedlinePlus. Fluticasone Oral Inhalation. https://medlineplus.gov/druginfo/meds/a601056.html
W19. MedlinePlus. Budesonide Oral Inhalation. https://medlineplus.gov/druginfo/meds/a699056.html
W20. MedlinePlus. Montelukast. https://medlineplus.gov/druginfo/meds/a600014.html
W21. MedlinePlus. Zileuton. https://medlineplus.gov/druginfo/meds/a697013.html
W22. MedlinePlus. Omalizumab Injection. https://medlineplus.gov/druginfo/meds/a603031.html
W23. MedlinePlus. Nicotine Transdermal Patch. https://medlineplus.gov/druginfo/meds/a601084.html
W24. MedlinePlus. Dextromethorphan. https://medlineplus.gov/druginfo/meds/a682492.html
W25. MedlinePlus. Guaifenesin. https://medlineplus.gov/druginfo/meds/a682494.html
W25A. MedlinePlus. Acetaminophen. https://medlineplus.gov/druginfo/meds/a681004.html
W26. NCBI Bookshelf, Nursing Skills. Chapter 11: Oxygen Therapy / oxygen-device settings. https://www.ncbi.nlm.nih.gov/books/NBK596733/